companydata.dkLABEX ApS: Financial statements 2026
CVR: 19947394
LABEX ApS (CVR 19947394) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 1,909,444 and a net result of DKK 991,782 compared with DKK 5,318 the year before. That is an increase of 117.4% compared with the year before. Equity amounted to DKK 1,789,042. The solvency ratio was 69.1%. The company had 1 employee in the financial year.
- Gross Profit
- 1,909,444 kr.
- Profit/Loss
- 991,782 kr.
- Equity
- 1,789,042 kr.
- Total Assets
- 2,587,260 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 1.9 mio. | 992 t. | 1.8 mio. | 1 |
| 2025 | - | 878 t. | 5 t. | 797 t. | 1 |
| 2024 | - | 1.5 mio. | 18 t. | 792 t. | 1 |
| 2023 | - | 2.5 mio. | 74 t. | 774 t. | 3 |
| 2022 | - | 2.4 mio. | -155 t. | 700 t. | 3 |
Keep an eye on LABEX ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2026
LABEX ApS has won the tender "Blodbestråler til AUH, Blodbank og Immunologi" issued by Region Midtjylland worth 4,300,000 DKK.
About LABEX ApS
LABEX ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 1996. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Max Pihlqvist. The company is owned by Svenska Labex AB. The company has 1 employee. In 2026, the company reported a gross profit of DKK 1,909,444 and a net result of DKK 991,782 compared with DKK 5,318 the year before. Equity amounted to DKK 1,789,042.